Cannabis Report
High Times
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 9/12/2018 3:06:35 PM - Followers: 30 - Board type: Free - Posts Today: 0
Cannabis Report
High Times
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: European Medicines Agency Validates Bristol-Myers Squibb’s Application for Empliciti (elotuzumab) Plus Pomalidomide & Low-D... 09/18/2018 06:59:00 AM
BMY News: Bristol-Myers Squibb Announces Dividend 09/12/2018 04:10:00 PM
BMY News: Bristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate... 09/12/2018 02:01:00 AM
BMY News: Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference 09/06/2018 03:00:00 PM
BMY News: Bristol-Myers Squibb to Announce Results for Third Quarter 2018 on October 25 09/06/2018 06:59:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#791  Sticky Note BMY 2Q18 results—note Eliquis growth: DewDiligence 07/26/18 10:46:16 AM
#798   BMY’s play to be a player in psoriasis DewDiligence 09/12/18 03:06:35 PM
#797   PFE sells $5B of debt: DewDiligence 09/05/18 10:11:39 AM
#796   FDA approves Opdivo monothearpy for third-line SCLC: #msg-142984905. DewDiligence 08/17/18 11:39:45 AM
#795   Transcript of BMY 2Q18 CC: DewDiligence 07/27/18 08:35:57 AM
#794   Told everyone Eliquis was heading to 7 billion Johnny_C 07/27/18 07:30:56 AM
#793   BMY was trading up 3% in early trading, DewDiligence 07/26/18 10:47:13 AM
#792   BMY/PFE—Eliquis grew 40%(!) YoY in 2Q18 and is DewDiligence 07/26/18 10:46:54 AM
#791   BMY 2Q18 results—note Eliquis growth: DewDiligence 07/26/18 10:46:16 AM
#790   Earnings should be interesting. Still holding Johnny_C 07/24/18 07:44:34 AM
#789   FDA approves Opdivo/Yervoy in second-line CRC with MSI-H DewDiligence 07/11/18 11:23:18 AM
#788   Opdivo/Yervoy PDUFA in high-TMB 1L-NSCLC is 2/20/19: DewDiligence 06/21/18 04:29:32 PM
#787   BMY ASCO-CC slides: DewDiligence 06/05/18 10:04:07 AM
#786   BMY PR on PD-L1-neg patients in CHECKMATE-227: DewDiligence 06/04/18 04:08:05 PM
#784   NKTR-214 ASCO slides: #msg-141256817. DewDiligence 06/02/18 06:42:08 PM
#783   Hmmm. So how much time has to Johnny_C 05/21/18 08:19:50 AM
#782   BMY poised for a break out. Offers a Viking Crest 05/18/18 11:04:24 AM
#781   could be $60 before june 1 ASCO bwrbad 05/17/18 01:14:19 PM
#780   BMY ASCO lineup: DewDiligence 05/16/18 06:39:59 PM
#779   Street Punished BMY Excessively bwrbad 05/05/18 09:58:54 AM
#778   BMY independent director bought $250K of stock 4/30/18: DewDiligence 05/02/18 04:18:55 PM
#777   That’s what Ian’s odd interview which he talked Johnny_C 04/28/18 01:41:28 PM
#776   More attractive than it was a few months DewDiligence 04/27/18 01:24:06 PM
#775   Maybe now they will make a deal with Johnny_C 04/27/18 12:49:27 PM
#774   Transcript of BMY 1Q18 CC: DewDiligence 04/27/18 09:43:17 AM
#773   BMY raised 2018 non-GAAP EPS guidance to $3.35-3.45 DewDiligence 04/26/18 06:24:03 PM
#772   Looks very good for next Q --negatives are bwrbad 04/26/18 05:51:47 PM
#771   BMY 1Q18 results: DewDiligence 04/26/18 11:35:23 AM
#770   BMY TURNED ITS DIRECTION TO SOLID GREEN ON bwrbad 04/24/18 10:07:19 PM
#769   Hope earning report is better than expected bwrbad 04/23/18 12:31:37 PM
#768   BMY seems aiming for 45 bwrbad 04/23/18 12:03:41 PM
#767   BMY AACR-webcast slides: DewDiligence 04/16/18 06:02:00 PM
#766   BMY, JNJ ink collaboration to develop/commercialize BMS-986177: #msg-140083631. DewDiligence 04/16/18 04:57:25 PM
#765   Anyone buying BMY on the plunge? $1.60 dividend biotech_researcher 04/16/18 02:21:42 PM
#764   FDA approves Opdivo/Yervoy combo in first-line RCC: DewDiligence 04/16/18 01:17:08 PM
#763   CHECKMATE-227 study in NSCLC disappoints: #msg-140073655. DewDiligence 04/16/18 12:12:19 PM
#761   Lung cancer battle brews Lung cancer drug trial data biotech_researcher 04/14/18 04:06:57 PM
#760   Bristol Myers Squibb $BMY Tests Key Level, Here ITMS 04/12/18 12:09:52 PM
#759   BMY -3% on this blurb re PFE’s (lack DewDiligence 04/12/18 09:39:55 AM
#758   MRK +6%; BMY -1% on Keytruda KEYNOTE-042 results: #msg-139894079. DewDiligence 04/09/18 12:02:18 PM
#757   NKTR-214 JV clears HSR review—BMY can now start DewDiligence 04/04/18 01:32:16 PM
#756   True. But there is the upcoming Johnny_C 03/19/18 04:01:15 PM
#755   BMY's 1Q17 CC is back to the usual DewDiligence 03/14/18 09:51:29 AM
#754   Take 2 on BMY reporting before PFE. Johnny_C 03/14/18 09:23:25 AM
#753   FDA approves Opdivo monthly dosing and shorter infusion time: DewDiligence 03/06/18 11:42:51 AM
#751   Re: PFE-BMY DewDiligence 02/24/18 01:48:52 PM
#750   Very Good deal for NKTR though, and utimately Johnny_C 02/15/18 04:32:56 PM
#749   Tiny Deal... Want some big news.... The PFE Johnny_C 02/15/18 09:16:40 AM
#748   BMY, NKTR ink global collaboration for NKTR-214: DewDiligence 02/14/18 08:16:41 AM
#747   This Leading Pharma Stock Breaks Its 200-Day Moving Average ITMS 02/06/18 11:54:22 AM
#746   (Revised)—Musings on CHECKMATE-227 results: #msg-138300300. DewDiligence 02/05/18 06:29:45 PM
PostSubject